Search research articles
Contact Us
Filters
Showing results (121-130 of 197) with videos related to
Page
of 20
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
December 16, 2024
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?
Dave Singh, MeiLan K Han, Surya P Bhatt, et al.
Pulmonary Therapy
|
March 18, 2020
Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis
David M G Halpin, Eckard H Hamelmann, Peter A Frith, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
March 10, 2021
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
Jean Bourbeau, Mona Bafadhel, Neil C Barnes, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
December 11, 2023
Any Decrease in Lung Function is Associated With Worse Clinical Outcomes: Post Hoc Analysis of the IMPACT Interventional Trial
MeiLan K Han, Gerard J Criner, David M G Halpin, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 8, 2021
Reply to Thomson, to Neder <i>et al</i>., and to Wouters
MeiLan K Han, Alvar Agusti, Bartolome R Celli, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 19, 2020
From GOLD 0 to Pre-COPD
MeiLan K Han, Alvar Agusti, Bartolome R Celli, et al.
Clinical and Translational Allergy
|
August 28, 2019
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
David B Price, Sinthia Bosnic-Anticevich, Ian D Pavord, et al.
Respiratory Research
|
April 2, 2024
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
Afisi S Ismaila, Kieran J Rothnie, Robert P Wood, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
April 30, 2020
Reducing the hidden burden of severe asthma: recognition and referrals from primary practice
Marc Humbert, Arnaud Bourdin, Nikolaos G Papadopoulos, et al.
The Lancet. Global Health
|
September 16, 2022
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review
Marie Stolbrink, Helen Thomson, Ruth M Hadfield, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 197) with videos related to
Sort By:
Page
of 20
American Journal of Respiratory and Critical Care Medicine
|
December 16, 2024
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?
Dave Singh, MeiLan K Han, Surya P Bhatt, et al.
Pulmonary Therapy
|
March 18, 2020
Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis
David M G Halpin, Eckard H Hamelmann, Peter A Frith, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
March 10, 2021
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
Jean Bourbeau, Mona Bafadhel, Neil C Barnes, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
December 11, 2023
Any Decrease in Lung Function is Associated With Worse Clinical Outcomes: Post Hoc Analysis of the IMPACT Interventional Trial
MeiLan K Han, Gerard J Criner, David M G Halpin, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 8, 2021
Reply to Thomson, to Neder <i>et al</i>., and to Wouters
MeiLan K Han, Alvar Agusti, Bartolome R Celli, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 19, 2020
From GOLD 0 to Pre-COPD
MeiLan K Han, Alvar Agusti, Bartolome R Celli, et al.
Clinical and Translational Allergy
|
August 28, 2019
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
David B Price, Sinthia Bosnic-Anticevich, Ian D Pavord, et al.
Respiratory Research
|
April 2, 2024
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
Afisi S Ismaila, Kieran J Rothnie, Robert P Wood, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
April 30, 2020
Reducing the hidden burden of severe asthma: recognition and referrals from primary practice
Marc Humbert, Arnaud Bourdin, Nikolaos G Papadopoulos, et al.
The Lancet. Global Health
|
September 16, 2022
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review
Marie Stolbrink, Helen Thomson, Ruth M Hadfield, et al.
Page
of 20